Opioid use disorder (OUD) during pregnancy presents serious health challenges for both the mother and her baby. Access to consistent treatment can be difficult due to barriers like transportation, childcare, stigma, and physical limitations. Fortunately, telehealth MAT for pregnant women with opioid use disorder is emerging as an effective and accessible solution that helps pregnant individuals continue vital treatment throughout pregnancy and beyond.
A recent study by Workit Health, a virtual addiction treatment provider, examined electronic health record (EHR) data from pregnant patients receiving medication-assisted treatment (MAT) for OUD. Published in JAMA, the research showed that nearly 80% of these patients received continuous opioid medication during pregnancy. Of those, 92% continued their treatment using telehealth services, highlighting the growing role of telehealth MAT for pregnant women with substance use disorder.
Continuity of Care Through Telehealth
One particularly encouraging finding was that 94.2% of patients who stayed engaged with telehealth MAT for pregnant women with opioid use disorder remained in treatment through six weeks postpartum. This period is critical, as it carries a high risk of relapse and overdose. The ability to maintain care remotely offers a lifeline for many who might otherwise face significant challenges in attending in-person appointments.
The study also found that 43% of participants were already pregnant at their initial telehealth visit, while 57.4% became pregnant after establishing care. Those who started MAT before pregnancy were more likely to stay engaged in telehealth MAT for pregnant women with substance use disorder, underscoring the importance of early intervention and continuous care.
The Promise of Low-Barrier, Technology-Integrated Care
Marlene Lira, Workit Health’s health director of research, emphasized the potential of this approach:
“The compelling outcomes of our telemedicine model speak to the promise of low-barrier, patient-led, and technology-integrated care for this high-risk population.” Her statement reinforces how telehealth MAT for pregnant women with substance use disorder can reduce barriers and empower patients to manage their health more effectively.
Beyond telehealth, programs like Elevance Health’s Empower peer specialist initiative are complementing medical treatment with emotional and social support. Designed for women between 18 and 40 who have substance use disorder (SUD) or are at risk, this program reflects the growing recognition that recovery is multifaceted.
Why Telehealth Matters for Pregnant Individuals with OUD
Pregnancy often makes it hard for individuals to attend frequent clinic visits due to discomfort, transportation issues, or childcare needs. Telehealth removes these barriers by allowing patients to connect with providers from home. This flexibility leads to better appointment adherence, consistent medication use, and ultimately healthier outcomes.
For pregnant individuals facing opioid use disorder, telehealth MAT for pregnant women with opioid use disorder offers a patient-centered approach that integrates technology with compassionate care. By reducing stigma and logistical challenges, telehealth encourages more people to seek and stay in treatment.
Getting Help with Telehealth MAT for Pregnant Women with Opioid Use Disorder
If you or someone you know is pregnant and struggling with opioid use disorder, know that telehealth MAT for pregnant women with addiction programs are available and can provide the support needed to maintain recovery safely throughout pregnancy and postpartum.
